Does diagnosis of metabolic syndrome predict the likelihood of peripheral arterial disease as defined by a low ankle-brachial index?

European Journal of Preventive Cardiology

Volumn 15, Issue 6, 2008, Pages 693-697

  Lã³pez Suã¡rez, Alejandro ^a   Beltrã¡n Robles, Manuel ^a   Elvira Gonzã¡lez, Javier ^a   Alwakil, Michael ^b   Bascuã±ana Quirell, Antonio ^a   Rosal Obrador, Joan ^a   Badani Gutiã©rrez, Hugo ^c   Oliver Pece, Miguel ^b   Pons Raga, Amparo ^d   Ruiz Decastroviejo, Juan ^b   Caã±as Hormigo, Francisco ^e   Benã­tez Rodrã­guez, Encarnaciã³n ^f  

^a Internal Medicine Department   (Spain)

^b Emergency Department   (Spain)

^c Nephrology Service   (Spain)

^d Intensive Care Unit   (Spain)

^e Instituto de Investigación Sanitaria de Navarra   (Spain)

^f HOSPITAL UNIVERSITARIO PUERTA DEL MAR   (Spain)

Author keywords

ankle brachial index; cardiovascular risk factors; metabolic syndrome; peripheral arterial disease

Indexed keywords

ADULT; AGED; ANKLE BRACHIAL INDEX; ARTERY DISEASE; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; POPULATION BASED CASE CONTROL STUDY; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RANDOM SAMPLE; SCREENING; ANKLE; BLOOD PRESSURE; BRACHIAL ARTERY; COMPARATIVE STUDY; MASS SCREENING; MIDDLE AGED; PATHOPHYSIOLOGY; PERIPHERAL VASCULAR DISEASE; PREDICTION AND FORECASTING; PROSPECTIVE STUDY; RISK; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; TIME; VASCULARIZATION;

AGED; ANKLE; BLOOD PRESSURE; BRACHIAL ARTERY; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FEMALE; HUMANS; LIKELIHOOD FUNCTIONS; MALE; MASS SCREENING; METABOLIC SYNDROME X; MIDDLE AGED; ODDS RATIO; PERIPHERAL VASCULAR DISEASES; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS;

EID: 64749110343     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1097/HJR.0b013e32830c1cc5     Document Type: Article

References (27)

1. Selvin E, Erlinger TP. Prevalence of risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999–2000. Circulation 2004; 110: 738–743.
2. Moler ER. Peripheral artery disease. Identification and implications. Arch Intern Med 2003; 163: 2306–2314.
3. Wautrecht JC, Dramaix M, De Backer G, Kornitzer M. Ankle brachial index is an independent predictor of all-cause and coronary mortality in healthy middle-aged working Belgian men after eighteen year follow-up Eur J Cardiovasc Prev Rehabil 2006; 13 (Suppl 1):S26–S27.
4. Garni AS, Witt BJ, Howard DE, Erwin PJ, Garni LA, Somers VK, et al Metabolic syndrome and risk of incident cardiovascular events and death. J Am Coll Cardiol 2007; 49: 403–414.
5. Guidelines for the Management of Arterial Hypertension. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25: 1105–1187.
6. Wang J, Ruotsalainen S, Moilanen L, Lepistö P, Laakso M, Kuusisto J. The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns. Eur Heart J 2007; 28: 857–864.
7. Stern MP, Williams K, Hunt KJ. Impact on diabetes/metabolic syndrome in patients with established cardiovascular disease. Atheroscler Suppl 2005; 6: 3–6.
8. Sone H, Mizuno S, Fujii H, Yoshimura Y, Yamasaki Y, Ishibashi S, et al Is the diagnosis of metabolic syndrome useful for predicting cardiovascular disease in Asian diabetic patients? Analysis from the Japan Diabetes Complications Study. Diabetes Care 2005; 28: 1463–1471.
9. Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: time for a critical appraisal. A Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005; 28: 2289–2304.
10. Fadini GP, Coracina A, Inchiostro S, Tiengo A, Avogaro A, de Kreutzenberg SV. A stepwise approach to assess the impact of clustering cardiometabolic risk factors on carotid intima-media thickness: the metabolic syndrome no-more-than additive. Eur J Cardiovasc Prev Rehabil 2008; 15: 190–196.
11. The Diabetes Epidemiology: Collaborative analysis of Diagnostic Criteria in Europe (DECODE) Study Group. Does diagnosis of the metabolic syndrome detect further men at high risk of cardiovascular death beyond those identified by a conventional cardiovascular risk score? The DECODE Study. Eur J Cardiovasc Prev Rehabil 2007; 14: 192–199.
12. Medrano MJ, Boix R, Cerrato E, Ramirez M. Incidence and prevalence of ischaemic heart disease and cerebrovascular disease in Spain: a systematic review of the literature. Rev Esp Salud Pública 2006; 80: 5–15.
13. Isomaa BO, Almgren P, Tuomi T, Forsen B, Lahti K, Nissén M, et al Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24: 683–689.
14. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499–502.
15. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412–419.
16. O'Braien E, De Gaudemairs R, Bobrie G, Agabiti Rosei E, Vaisse B. Proceedings from the First International Consensus Conference on Self-Blood Pressure Measurement. Devices and validation. Blood Press Monit 2000; 5: 93–100.
17. Resnick HE, Lindsay RS, McGrae M, Devereux RB, Jones KL, Fabsitz RR, et al Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: the Strong Heart Study. Circulation 2004; 109: 733–739.
18. Wattanakit K, Folsom AR, Duprez DA, Weatherley BD, Hirsh AT. Clinical significance of a high ankle-brachial index: insights from the Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis 2007; 190: 459–464.
19. Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant C; for the Conference Participants. Definition of metabolic syndrome. Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition Circulation 2004; 109: 433–438.
20. Alberti KGM, Zimmet P, Shaw J; IDF Epidemiology Task Force Consensus Group. The metabolic syndrome: a new worldwide definition Lancet 2005; 366: 1059–1062.
21. Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome. A summary of the evidence. Diabetes Care 2005; 28: 1769–1777.
22. Tong P, Kong A, So WY, Yang X, Ho CS, Ronald C, et al The usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III Definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes. Diabetes Care 2007; 30: 1206–1211.
23. Cull CA, Jensen CC, Retmakaran R, Holman RR. Impact of the metabolic syndrome on macrovascular and microvascular outcomes in type 2 diabetes mellitus. United Kingdom Prospective Diabetes Study 78. Circulation 2007; 116: 2119–2126.
24. Olijhoek JK, van der Graaf Y, Banga JD, Algra A, Rabelink TJ, Visseren FL. The metabolic syndrome is associated with advanced vascular damage in patients with coronary heart disease, stroke, peripheral arterial disease or abdominal aortic aneurysm. Eur Heart J 2004; 25: 342–348.
25. Wang J, Ruotsalainen S, Moilanen L, Lepistö P, Laakso M, Kuusisto J. Metabolic syndrome and incident end-stage peripheral vascular disease. A 14-year follow-up study in elderly Finns. Diabetes Care 2007; 30: 3099–3104.
26. Rana JS, Jansen AC, Zwinderman AH, Nieuwdorp M, van Aalst-Cohen ES, Jukema JW, et al Metabolic syndrome and risk of coronary, cerebral, and peripheral vascular disease in a large Dutch population with familial hypercholesterolemia. Diabetes Care 2006; 29: 1125–1127.
27. Lahoz C, Vicente I, Laguna F, García-lglesias MF, Taboada M, Mostaza JM. Peripheral artery disease in subjects over 60 years of age. Diabetes Care 2006; 29: 148–150.